Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 13, 2022 Filed Jan 14, 2022 22:09 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003364 · doc4.xml · derivative · entry 5 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,756 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:09 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003364 · doc4.xml · derivative · entry 4 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:09 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 2,012 | $8.30 | $16,699.60 |
DisclosureSEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,783 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:09 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,795 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:09 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003364 · doc4.xml · nonDerivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,231 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:08 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 16,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003362 · doc4.xml · derivative · entry 5 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,295 Underlying: Common Stock · 16,122 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:08 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003362 · doc4.xml · derivative · entry 4 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,104 Underlying: Common Stock · 3,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:08 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 5,219 | $8.30 | $43,317.70 |
DisclosureSEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 3 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,635 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:08 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 16,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 2 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,854 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:08 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003362 · doc4.xml · nonDerivative · entry 1 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:07 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003361 · doc4.xml · derivative · entry 5 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,756 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:07 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003361 · doc4.xml · derivative · entry 4 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:07 UTC |
POYHONEN JOHNPresident & CCO
|
Tax withholdingCommon Stock | 2,012 | $8.30 | $16,699.60 |
DisclosureSEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 3 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,638 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:07 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 2 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:07 UTC |
POYHONEN JOHNPresident & CCO
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003361 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,086 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:06 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,933 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003360 · doc4.xml · derivative · entry 5 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,491 Underlying: Common Stock · 1,933 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:06 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 552 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003360 · doc4.xml · derivative · entry 4 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,073 Underlying: Common Stock · 552 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:06 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 966 | $8.30 | $8,017.80 |
DisclosureSEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 3 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,716 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:06 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 1,933 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 2 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:06 UTC |
Peraza LisaVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 552 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003360 · doc4.xml · nonDerivative · entry 1 Peraza Lisa · CIK 0001828266 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:05 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 4,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003358 · doc4.xml · derivative · entry 5 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,756 Underlying: Common Stock · 4,564 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F4 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:05 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003358 · doc4.xml · derivative · entry 4 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:05 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Tax withholdingCommon Stock | 2,012 | $8.30 | $16,699.60 |
DisclosureSEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 3 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,070 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:05 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionCommon Stock | 4,564 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 2 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 22:05 UTC |
MANHARD KIMBERLYDirector · EVP, Drug Development
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-003358 · doc4.xml · nonDerivative · entry 1 MANHARD KIMBERLY · CIK 0001202094 · Director · EVP, Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 18:58 UTC |
Rodriguez SusanDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,903 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001209191-21-071170 · doc4.xml · derivative · entry 2 Rodriguez Susan · CIK 0001812511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,903 Underlying: Common Stock · 20,903 shares Expires 2031-12-22 F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 18:58 UTC |
Rodriguez SusanDirector
|
GrantCommon Stock | 10,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071170 · doc4.xml · nonDerivative · entry 1 Rodriguez Susan · CIK 0001812511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,702 F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:58 UTC |
Christian WaageDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,903 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001209191-21-071172 · doc4.xml · derivative · entry 3 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,903 Underlying: Common Stock · 20,903 shares Expires 2031-12-22 F4 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:58 UTC |
Christian WaageDirector
|
GrantCommon Stock | 10,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071172 · doc4.xml · nonDerivative · entry 2 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,652 F3 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:56 UTC |
Dissanaike SharmilaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,903 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001209191-21-071168 · doc4.xml · derivative · entry 2 Dissanaike Sharmila · CIK 0001885069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,903 Underlying: Common Stock · 20,903 shares Expires 2031-12-22 F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:56 UTC |
Dissanaike SharmilaDirector
|
GrantCommon Stock | 10,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071168 · doc4.xml · nonDerivative · entry 1 Dissanaike Sharmila · CIK 0001885069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,702 F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:57 UTC |
Johnson Craig ADirector
|
GrantStock Option (Right to Buy) · Derivative | 20,903 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001209191-21-071169 · doc4.xml · derivative · entry 3 Johnson Craig A · CIK 0001370348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,903 Underlying: Common Stock · 20,903 shares Expires 2031-12-22 F4 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:57 UTC |
Johnson Craig ADirector
|
GrantCommon Stock | 10,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071169 · doc4.xml · nonDerivative · entry 2 Johnson Craig A · CIK 0001370348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,292 F3 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:55 UTC |
DAVIS STEPHENDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,903 | $0.00 Strike: $9.81 | $0.00 |
DisclosureSEC source: 0001209191-21-071167 · doc4.xml · derivative · entry 2 DAVIS STEPHEN · CIK 0001131146 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,903 Underlying: Common Stock · 20,903 shares Expires 2031-12-22 F2 · derivative.exercise_date: The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant. Read SEC document |
| December 22, 2021 Filed Dec 23, 2021 23:55 UTC |
DAVIS STEPHENDirector
|
GrantCommon Stock | 10,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071167 · doc4.xml · nonDerivative · entry 1 DAVIS STEPHEN · CIK 0001131146 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,452 F1 · shares: The shares were granted as restricted stock units which vest in full on December 22, 2022. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 23:58 UTC |
Christian WaageDirector
|
SaleCommon Stock | 300 | $9.73 | $2,920.35 |
DisclosureSEC source: 0001209191-21-071172 · doc4.xml · nonDerivative · entry 1 Christian Waage · CIK 0001553179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021. F2 · price: The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 23:57 UTC |
Johnson Craig ADirector
|
SaleCommon Stock | 250 | $9.73 | $2,431.93 |
DisclosureSEC source: 0001209191-21-071169 · doc4.xml · nonDerivative · entry 1 Johnson Craig A · CIK 0001370348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,840 F1 · kind: The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 3, 2021. The shares were sold by Mr. Johnson to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021. F2 · price: The range of sales prices received was $9.625 to $9.845. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Read SEC document |
| October 29, 2021 Filed Dec 23, 2021 23:59 UTC |
POYHONEN JOHNPresident & CCO
|
OtherCommon Stock | 817 | $9.36 | $7,645.89 |
DisclosureSEC source: 0001209191-21-071173 · doc4.xml · nonDerivative · entry 1 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,836 F1 · kind: Represents shares acquired under the Heron Therapeutics, Inc. 1997 Employee Stock Purchase Plan on October 29, 2021. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:25 UTC |
Quart Barry DDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 195,417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 5 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,417 Underlying: Common Stock · 195,417 shares Expires not disclosed F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:25 UTC |
Quart Barry DDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 390,834 | $0.00 Strike: $10.55 | $0.00 |
DisclosureSEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 4 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,834 Underlying: Common Stock · 390,834 shares Expires 2031-10-13 F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:25 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060551 · doc4.xml · derivative · entry 3 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,750 Underlying: Common Stock · 3,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:25 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 963 | $10.55 | $10,159.65 |
DisclosureSEC source: 0001209191-21-060551 · doc4.xml · nonDerivative · entry 2 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,086 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:25 UTC |
Quart Barry DDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 3,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-060551 · doc4.xml · nonDerivative · entry 1 Quart Barry D · CIK 0001384243 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:26 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
GrantRestricted Stock Units · Derivative | 55,320 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 5 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,320 Underlying: Common Stock · 55,320 shares Expires not disclosed F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:26 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 92,200 | $0.00 Strike: $10.55 | $0.00 |
DisclosureSEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 4 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,200 Underlying: Common Stock · 92,200 shares Expires 2031-10-13 F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:26 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060553 · doc4.xml · derivative · entry 3 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). F3 · derivative.expiration_date: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:26 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Tax withholdingCommon Stock | 433 | $10.55 | $4,568.15 |
DisclosureSEC source: 0001209191-21-060553 · doc4.xml · nonDerivative · entry 2 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,981 F2 · acquired: Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:26 UTC |
Szekeres David LeslieEVP, Chief Operating Officer
|
Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-060553 · doc4.xml · nonDerivative · entry 1 Szekeres David Leslie · CIK 0001602459 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,414 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:24 UTC |
POYHONEN JOHNPresident & CCO
|
GrantRestricted Stock Units · Derivative | 55,320 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060550 · doc4.xml · derivative · entry 5 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,320 Underlying: Common Stock · 55,320 shares Expires not disclosed F5 · derivative.exercise_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. F5 · derivative.expiration_date: The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 20:24 UTC |
POYHONEN JOHNPresident & CCO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 92,200 | $0.00 Strike: $10.55 | $0.00 |
DisclosureSEC source: 0001209191-21-060550 · doc4.xml · derivative · entry 4 POYHONEN JOHN · CIK 0001286100 · President & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,200 Underlying: Common Stock · 92,200 shares Expires 2031-10-13 F4 · derivative.exercise_date: The stock option vests and becomes exercisable monthly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that the stock option will be fully vested on the four year anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.